Screening of selective inhibitors of 1α,25-dihydroxyvitamin D3 24-hydroxylase using recombinant human enzyme expressed in Escherichia coli.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Biochemistry

• Publication date

  2010-11-18

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/bi101488pPMID 21058632
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and CYP24A1 inhibitory activity of N-(2-(1H-imidazol-1-yl)-2-phenylethyl)arylamides.

  2010cited by this paper
• Crystal structure of CYP24A1, a mitochondrial cytochrome P450 involved in vitamin D metabolism.

  2010cited by this paper
• Nonclassic actions of vitamin D.

  2009cited by this paper
• The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action.

  2008cited by this paper
• Evolution of our understanding of vitamin D.

  2008cited by this paper
• Vitamin D analogs: therapeutic applications and mechanisms for selectivity.

  2008cited by this paper
• Hybrid homology modeling and mutational analysis of cytochrome P450C24A1 (CYP24A1) of the Vitamin D pathway: insights into substrate specificity and membrane bound structure-function.

  2007cited by this paper
• A 24-Phenylsulfone Analog of Vitamin D Inhibits 1α,25-Dihydroxyvitamin D3 Degradation in Vitamin D Metabolism-Competent Cells

  2007cited by this paper
• Generation of a homology model for the human cytochrome P450, CYP24A1, and the testing of putative substrate binding residues by site-directed mutagenesis and enzyme activity studies.

  2007cited by this paper
• Homology model of 1alpha,25-dihydroxyvitamin D3 24-hydroxylase cytochrome P450 24A1 (CYP24A1): active site architecture and ligand binding.

  2007cited by this paper
• Calcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination therapy to treat prostate cancer.

  2007cited by this paper
• Epigenetic Silencing of CYP24 in Tumor-derived Endothelial Cells Contributes to Selective Growth Inhibition by Calcitriol*

  2007cited by this paper
• Vitamin D signalling pathways in cancer: potential for anticancer therapeutics

  2007cited by this paper
• 2MD, a new anabolic agent for osteoporosis treatment

  2006cited by this paper
• Structure-Function Analysis of Vitamin D 24-Hydroxylase (CYP24A1) by Site-Directed Mutagenesis: Amino Acid Residues Responsible for Species-Based Difference of CYP24A1 between Humans and Rats

  2006cited by this paper
• An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid.

  2006cited by this paper
• New 2-alkylidene 1alpha,25-dihydroxy-19-norvitamin D3 analogues of high intestinal activity: synthesis and biological evaluation of 2-(3'-alkoxypropylidene) and 2-(3'-hydroxypropylidene) derivatives.

  2006cited by this paper
• CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer

  2006cited by this paper
• Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines.

  2005cited by this paper
• Novel metabolism of 1 alpha,25-dihydroxyvitamin D3 with C24-C25 bond cleavage catalyzed by human CYP24A1.

  2004cited by this paper
• Potent, selective and low-calcemic inhibitors of CYP24 hydroxylase: 24-sulfoximine analogues of the hormone 1alpha,25-dihydroxyvitamin D(3).

  2004cited by this paper
• Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.

  2004cited by this paper
• Purification and characterization of mouse CYP27B1 overproduced by an Escherichia coli system coexpressing molecular chaperonins GroEL/ES.

  2004cited by this paper
• Role of 24‐hydroxylase in vitamin D3 growth response of OVCAR‐3 ovarian cancer cells

  2004cited by this paper
• Enzymes involved in the activation and inactivation of vitamin D.

  2004cited by this paper
• Potent, low-calcemic, selective inhibitors of CYP24 hydroxylase: 24-sulfone analogs of the hormone 1alpha,25-dihydroxyvitamin D3.

  2004cited by this paper
• Synthesis and CYP24 inhibitory activity of 2-substituted-3,4-dihydro-2H-naphthalen-1-one (tetralone) derivatives.

  2004cited by this paper
• Rat cytochrome P450C24 (CYP24A1) and the role of F249 in substrate binding and catalytic activity.

  2004cited by this paper
• Inhibitors of vitamin D hydroxylases: Structure–activity relationships

  2003cited by this paper
• Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells.

  2002cited by this paper
• A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formation.

  2002cited by this paper
• Non-oxidative decarboxylation of glycine derivatives by a peroxidase.

  2002cited by this paper
• Newly Established Assay Method for 25‐Hydroxyvitamin D3 24‐Hydroxylase Revealed Much Lower Km for 25‐Hydroxyvitamin D3 than for 1α,25‐Dihydroxyvitamin D3

  2001cited by this paper
• Inactivation of C30A trimethylamine dehydrogenase by N-cyclopropyl-alpha-methylbenzylamine, 1-phenylcyclopropylamine, and phenylhydrazine.

  2001cited by this paper
• Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24.

  2000cited by this paper
• Enzymatic properties of mouse 25-hydroxyvitamin D3 1 alpha-hydroxylase expressed in Escherichia coli.

  1999cited by this paper
• A colorimetric assay for heme in biological samples using 96-well plates.

  1999cited by this paper
• Escherichia coli maltose‐binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused

  1999cited by this paper
• Metabolic studies using recombinant escherichia coli cells producing rat mitochondrial CYP24 CYP24 can convert 1alpha,25-dihydroxyvitamin D3 to calcitroic acid.

  1999cited by this paper
• Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity.

  1999cited by this paper
• Cloning and expression of the chicken 25-hydroxyvitamin D3 24-hydroxylase cDNA.

  1998cited by this paper
• A highly sensitive method for large-scale measurements of 1,25-dihydroxyvitamin D.

  1998cited by this paper
• Chaperone Coexpression Plasmids: Differential and Synergistic Roles of DnaK-DnaJ-GrpE and GroEL-GroES in Assisting Folding of an Allergen of Japanese Cedar Pollen, Cryj2, inEscherichia coli

  1998cited by this paper
• New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues.

  1998cited by this paper
• Human 25-hydroxyvitamin D3-24-hydroxylase, a multicatalytic enzyme.

  1996cited by this paper
• Novel 19-(cyclopropylamino)-androst-4-en-3,17-dione: a mechanism-based inhibitor of aromatase.

  1996cited by this paper
• Further oxidation of hydroxycalcidiol by calcidiol 24-hydroxylase. A study with the mature enzyme expressed in Escherichia coli.

  1994cited by this paper
• Direct expression of adrenodoxin reductase in Escherichia coli and the functional characterization.

  1993cited by this paper
• Reaction of lysyl oxidase with trans-2-phenylcyclopropylamine.

  1993cited by this paper
• Isolation and expression of human 1,25-dihydroxyvitamin D3 24-hydroxylase cDNA.

  1993cited by this paper
• Direct expression in Escherichia coli and characterization of bovine adrenodoxins with modified amino‐terminal regions

  1992cited by this paper
• Cloning and expression of cDNA encoding 25‐hydroxyvitamin D3 24‐hydroxylase

  1991cited by this paper
• 17 beta-(cyclopropylamino)-androst-5-en-3 beta-ol, a selective mechanism-based inhibitor of cytochrome P450(17 alpha) (steroid 17 alpha-hydroxylase/C17-20 lyase).

  1989cited by this paper
• Ketoconazole inhibits self-induced metabolism of 1,25-dihydroxyvitamin D3 and amplifies 1,25-dihydroxyvitamin D3 receptor up-regulation in rat osteosarcoma cells.

  1989cited by this paper
• Assay and properties of 25-hydroxyvitamin D3 23-hydroxylase. Evidence that 23,25-dihydroxyvitamin D3 is a major metabolite in 1,25-dihydroxyvitamin D3-treated or fasted guinea pigs.

  1988cited by this paper
• Induction of monocytic differentiation of HL-60 cells by 1,25-dihydroxyvitamin D analogs.

  1987cited by this paper
• 25-Hydroxyvitamin D3-23-hydroxylase, a renal enzyme in several animal species.

  1986cited by this paper
• Monoclonal antibodies to the porcine intestinal receptor for 1,25-dihydroxyvitamin D3: interaction with distinct receptor domains.

  1986cited by this paper
• Cyclopropylamines as suicide substrates for cytochromes P-450.

  1979cited by this paper
• Purification of adrenodoxin reductase, adrenodoxin, and cytochrome P-450 from adrenal cortex.

  1978cited by this paper
• Purification and crystallization of NADPH‐adrenodoxin reductase from bovine adrenocortical mitochondria

  1975cited by this paper
• Studies on adrenal steroid hydroxylases: optical absorption spectroscopy of adrenal iron-sulfur protein (adrenodoxin) and its apoprotein.

  1970cited by this paper
• THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. II. SOLUBILIZATION, PURIFICATION, AND PROPERTIES.

  1964cited by this paper
• A new method for preparing flavin-adenine dinucleotide.

  1953cited by this paper

• Identification of kinase inhibitors that rule out the CYP27B1-mediated activation of vitamin D: an integrated machine learning and structure-based drug designing approach

  2021cites this paper
• Small molecule inhibitors of 25 hydroxyvitamin D 24 hydroxylase ( CYP 24 A 1 ) : synthesis and biological evaluation

  2019cites this paper
• Synthesis and Biological Evaluation of Cyclopropylamine Vitamin D‐Like CYP24A1 Inhibitors

  2017cites this paper
• Synthesis, molecular modelling and CYP24A1 inhibitory activity of novel of (E)-N-(2-(1H-imidazol-1-yl)-2-(phenylethyl)-3/4-styrylbenzamides.

  2017influential citation
• Analysis of the binding sites of vitamin D 1α-hydroxylase (CYP27B1) and vitamin D 24-hydroxylase (CYP24A1) for the design of selective CYP24A1 inhibitors: Homology modelling, molecular dynamics simulations and identification of key binding requirements.

  2017cites this paper
• Motor neuron-like NSC-34 cells as a new model for the study of vitamin D metabolism in the brain.

  2016cites this paper
• Inhibition of Cytochrome P450 Enzymes

  2015cites this paper
• The kinetic characterisation of vitamin D metabolism by human CYP24A1

  2015cites this paper
• Kinetic analysis of human CYP24A1 metabolism of vitamin D via the C24‐oxidation pathway

  2014cites this paper
• Novel, Selective Vitamin D Analog Suppresses Parathyroid Hormone in Uremic Animals and Postmenopausal Women

  2014cites this paper
• Small-molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): synthesis and biological evaluation.

  2014cites this paper
• Novel styryl-indoles as small molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): Synthesis and biological evaluation.

  2014cites this paper
• Synthesis and Biological Activity of 25-Hydroxy-2-methylene-vitamin D3 analogues monohydroxylated in the A-ring.

  2014cites this paper
• Small molecule inhibitors of CYP24A1 for the treatment of various cancers

  2013cites this paper
• Rat CYP24A1 acts on 20-hydroxyvitamin D(3) producing hydroxylated products with increased biological activity.

  2012cites this paper
• Analogues de n-cyclopropyl-(20r)-2-méthylène-19,26,27-trinor-25-aza-vitamine d et leurs utilisations

  2012cites this paper
• Synthesis and biological activities of vitamin D-like inhibitors of CYP24 hydroxylase.

  2012influential citation
• Imaging , Diagnosis , Prognosis CYP 24 A 1 Is an Independent Prognostic Marker of Survival in Patients with Lung Adenocarcinoma

  2011cites this paper
• CYP24A1 Is an Independent Prognostic Marker of Survival in Patients with Lung Adenocarcinoma

  2010cites this paper